Works matching IS 11753277 AND DT 2025 AND VI 25 AND IP 2
Results: 13
Prevention of New-Onset Heart Failure in Atrial Fibrillation: The Role of Pharmacological Management: Prevention of New-Onset Heart Failure in Atrial Fibrillation: A.Zobdeh et al.
- Published in:
- American Journal of Cardiovascular Drugs, 2025, v. 25, n. 2, p. 147, doi. 10.1007/s40256-024-00703-y
- By:
- Publication type:
- Article
A Meta-analysis of the Regulation of Low-Density Lipoprotein Cholesterol and Proprotein Convertase Subtilisin-Kexin Type 9 with Inclisiran: Regulation of LDL-C and PCSK9 with Inclisiran: Y. Li et al.
- Published in:
- American Journal of Cardiovascular Drugs, 2025, v. 25, n. 2, p. 191, doi. 10.1007/s40256-024-00702-z
- By:
- Publication type:
- Article
Safety of Vericiguat in Patients with Coronary Artery Disease: A Systematic Review and Meta-analysis: Safety of Vericiguat in Patients with CAD: M. B. Zarti, A. Tamgheli.
- Published in:
- American Journal of Cardiovascular Drugs, 2025, v. 25, n. 2, p. 241, doi. 10.1007/s40256-024-00701-0
- By:
- Publication type:
- Article
Impact of Renal Function Estimation Formulae on Use and Correct Dosing of NOACs in Patients with Non-valvular Atrial Fibrillation in Real Life in Germany: Impact of Renal Function Estimation Formulae: U. Zeymer et al.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Sacubitril–Valsartan Lowers Atrial Fibrillation Recurrence and Left Atrial Volume Post-catheter Ablation: Systematic Review and Meta-Analysis: Sacubitril–Valsartan Versus ACEi/ARB After Catheter Ablation: L. A. de Lucena et al.
- Published in:
- American Journal of Cardiovascular Drugs, 2025, v. 25, n. 2, p. 157, doi. 10.1007/s40256-024-00691-z
- By:
- Publication type:
- Article
Pharmacokinetic Drug–Drug Interaction between Cilostazol and Rosuvastatin in Healthy Participants: Pharmacokinetic Drug–Drug Interaction: D. H. Kim et al.
- Published in:
- American Journal of Cardiovascular Drugs, 2025, v. 25, n. 2, p. 267, doi. 10.1007/s40256-024-00686-w
- By:
- Publication type:
- Article
Levosimendan in Patients with Cardiogenic Shock Refractory to Dobutamine Weaning: Levosimendan in Cardiogenic Shock: M. Zeitouni et al.
- Published in:
- American Journal of Cardiovascular Drugs, 2025, v. 25, n. 2, p. 249, doi. 10.1007/s40256-024-00683-z
- By:
- Publication type:
- Article
Real-Life Individual Comparison of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure and Diabetes Mellitus: Real-Life Individual Comparison of Sodium-Glucose Cotransporter-2 Inhibitors: M. B. Yilmaz et al.
- Published in:
- American Journal of Cardiovascular Drugs, 2025, v. 25, n. 2, p. 277, doi. 10.1007/s40256-024-00698-6
- By:
- Publication type:
- Article
Use of Direct Anticoagulants in Kidney Transplant Recipients: Review of the Current Evidence and Emerging Perspectives: Direct Oral Anticoagulants in Kidney transplantation: B. Afsar et al.
- Published in:
- American Journal of Cardiovascular Drugs, 2025, v. 25, n. 2, p. 135, doi. 10.1007/s40256-024-00692-y
- By:
- Publication type:
- Article
A Systematic Review and Meta-Analysis of the Safety and Efficacy of SGLT2 Inhibitors in Chronic Heart Failure in ACHD Patients: SGLT2i in Heart Failure Due to ACHD: Bibhuti B. Das, Jianli Niu.
- Published in:
- American Journal of Cardiovascular Drugs, 2025, v. 25, n. 2, p. 231, doi. 10.1007/s40256-024-00697-7
- By:
- Publication type:
- Article
Role of Incretin Mimetics in Cardiovascular Outcomes and Other Classical Cardiovascular Risk Factors beyond Obesity and Diabetes Mellitus in Nondiabetic Adults with Obesity: a Meta-analysis of Randomized Controlled Trials: Role of Incretin Mimetics in Cardiovascular Outcomes: W. Kamarullah et al
- Published in:
- American Journal of Cardiovascular Drugs, 2025, v. 25, n. 2, p. 203, doi. 10.1007/s40256-024-00695-9
- By:
- Publication type:
- Article
Cost Effectiveness of Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: A Systematic Review and Meta-analysis: Cost Effectiveness of Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: L. Wattanasukchai et al.
- Published in:
- American Journal of Cardiovascular Drugs, 2025, v. 25, n. 2, p. 169, doi. 10.1007/s40256-024-00693-x
- By:
- Publication type:
- Article
Impact of Antibacterials on the Quality of Anticoagulation Control in Patients Initiating Warfarin Therapy: Antibacterials and Warfarin Control: K. Sugiyama et al.
- Published in:
- American Journal of Cardiovascular Drugs, 2025, v. 25, n. 2, p. 259, doi. 10.1007/s40256-024-00690-0
- By:
- Publication type:
- Article